For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

 

Crossref Citations

1. Can routine antenatal data be used to assess HIV antiretroviral therapy coverage among pregnant women? Evaluating the validity of different data sources in the Western Cape, South Africa
Nisha Jacob, Brian Rice, Alexa Heekes, Leigh F. Johnson, Samantha Brinkmann, Tendesayi Kufa, Andrew Boulle, Muhammad Osman
PLOS ONE  vol: 19  issue: 4  first page: e0291844  year: 2024  
doi: 10.1371/journal.pone.0291844

2. Dolutegravir Resistance in African Programmatic Settings Among Patients With Failure of Dolutegravir-based ART
Richard A Murphy, Pradeep H Bedesi, Nirmala Perumal, Bernadett I Gosnell, Timothy J Hatlen, Jaysingh Brijkumar
Open Forum Infectious Diseases  vol: 11  issue: 7  year: 2024  
doi: 10.1093/ofid/ofae321

3. Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study
Mhairi Maskew, Vinolia Ntjikelane, Allison Juntunen, Nancy Scott, Mariet Benade, Linda Sande, Pamfred Hasweeka, Prudence Haimbe, Priscilla Lumano-Mulenga, Hilda Shakewelele, Mpande Mukumbwa-Mwenechanya, Sydney Rosen
Gates Open Research  vol: 7  first page: 119  year: 2024  
doi: 10.12688/gatesopenres.14682.2

4. Moving towards the global HIV 95% viral suppression target
Pascal O Bessong, Lufuno G Mavhandu-Ramarumo
The Lancet HIV  vol: 8  issue: 12  first page: e731  year: 2021  
doi: 10.1016/S2352-3018(21)00273-3

5. Drivers of disengagement from care during the first six months on antiretroviral therapy for HIV in South Africa: A mixed-methods study
Mhairi Maskew, Nyasha Mutanda, Nancy Scott, Allison Morgan, Mariet Benade, Vinolia Ntjikelane, Linda Sande, Lufuno Malala, Musa Manganye, Sydney Rosen, Radhika Sundararajan
PLOS Global Public Health  vol: 5  issue: 12  first page: e0004977  year: 2025  
doi: 10.1371/journal.pgph.0004977

6. The unintended outcome: a retrospective cross‐sectional study using a urine lateral flow assay to detect ART use reveals non‐disclosure of taking ART in South Africa's public health system
Nsika Sithole, Indira Govender, Matthew Spinelli, Theresa Smit, Siyabonga Cibane, Mlungisi Zwane, Njabulo Phakathi, Meighan Krows, Busisiwe Nkosi, Janet Seeley, Ruanne V. Barnabas, Mark J. Siedner, Mosa Moshabela, Connie Celum, Alison Grant, Monica Gandhi, Adrienne E. Shapiro
Journal of the International AIDS Society  vol: 28  issue: 6  year: 2025  
doi: 10.1002/jia2.26515

7. Prior antiretroviral therapy exposure among clients presenting for HIV treatment initiation in South Africa: an exploratory mixed-methods study using multiple indicators of exposure
Mariet Benade, Mhairi Maskew, Vinolia Ntjikelane, Nancy Scott, Nkosinathi Ngcobo, Brooke Nichols, Lufuno Malala, Musa Manganye, Sydney Rosen
BMC Infectious Diseases  vol: 25  issue: 1  year: 2025  
doi: 10.1186/s12879-025-11340-4

8. Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study
Mhairi Maskew, Vinolia Ntjikelane, Allison Juntunen, Nancy Scott, Mariet Benade, Linda Sande, Pamfred Hasweeka, Prudence Haimbe, Priscilla Lumano-Mulenga, Hilda Shakewelele, Mpande Mukumbwa-Mwenechanya, Sydney Rosen
Gates Open Research  vol: 7  first page: 119  year: 2023  
doi: 10.12688/gatesopenres.14682.1

9. High prevalence of undisclosed antiretroviral drug use among individuals initiating HIV treatment in Gaborone, Botswana
Natasha O. Moraka, Sikhulile Moyo, Terence Mohammed, Kesaobaka Molebatsi, Lubbe Wiesner, Patrick T. Mokgethi, Irene Gobe, Margaret Mokomane, Salang T. Moutswi, Laone Rabatoko, Queen Leteemane, Vanessa Strachan-Amaro, Phenyo Sabone, Simani Gaseitsiwe
Frontiers in Public Health  vol: 13  year: 2025  
doi: 10.3389/fpubh.2025.1582940

10. Prior exposure to antiretroviral therapy among adult patients presenting for HIV treatment initiation or reinitiation in sub-Saharan Africa: a systematic review
Mariet Benade, Mhairi Maskew, Allison Juntunen, David B Flynn, Sydney Rosen
BMJ Open  vol: 13  issue: 11  first page: e071283  year: 2023  
doi: 10.1136/bmjopen-2022-071283

11. Dolutegravir regimens have transformed treatment, but ongoing drug resistance research is required to maintain success
Gert U. Van Zyl, Lauren Jennings, Helena Rabie, Catherine Orrell
AIDS  vol: 39  issue: 4  first page: 337  year: 2025  
doi: 10.1097/QAD.0000000000004099